{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T07:22:15Z","timestamp":1781076135746,"version":"3.54.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"NIH\/NAIDS","award":["P30-AI 060354"],"award-info":[{"award-number":["P30-AI 060354"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"DOI":"10.1186\/s13104-024-07032-y","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T08:26:23Z","timestamp":1736238383000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The prognosis for delayed immune recovery in HIV-infected children might be associated with pre-cART CD4+ T cell count irrespective of co-infection with tuberculosis"],"prefix":"10.1186","volume":"18","author":[{"given":"Funsho J.","family":"Ogunshola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruhul A.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Musie","family":"Ghebremichael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,7]]},"reference":[{"key":"7032_CR1","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a017871","volume":"5","author":"J Bruchfeld","year":"2015","unstructured":"Bruchfeld J, Correia-Neves M, K\u00e4llenius G. Tuberculosis and HIV coinfection. Cold Spring Harb Perspect Med. 2015;5: a017871. https:\/\/doi.org\/10.1101\/cshperspect.a017871.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"7032_CR2","doi-asserted-by":"publisher","first-page":"186","DOI":"10.4314\/gmj.v54i3.10","volume":"54","author":"K Torpey","year":"2020","unstructured":"Torpey K, et al. Management of TB\/HIV co-infection: the state of the evidence. Ghana Med J. 2020;54:186\u201396. https:\/\/doi.org\/10.4314\/gmj.v54i3.10.","journal-title":"Ghana Med J"},{"key":"7032_CR3","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1001\/jama.293.22.2767","volume":"293","author":"C Dye","year":"2005","unstructured":"Dye C, Watt CJ, Bleed DM, Hosseini SM, Raviglione MC. Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally. JAMA. 2005;293:2767\u201375. https:\/\/doi.org\/10.1001\/jama.293.22.2767.","journal-title":"JAMA"},{"key":"7032_CR4","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/s1473-3099(10)70078-5","volume":"10","author":"SD Lawn","year":"2010","unstructured":"Lawn SD, et al. Antiretrovirals and isoniazid preventive therapy in the prevention of HIV-associated tuberculosis in settings with limited health-care resources. Lancet Infect Dis. 2010;10:489\u201398. https:\/\/doi.org\/10.1016\/s1473-3099(10)70078-5.","journal-title":"Lancet Infect Dis"},{"key":"7032_CR5","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1001\/jama.2016.8900","volume":"316","author":"HF G\u00fcnthard","year":"2016","unstructured":"G\u00fcnthard HF, et al. Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2016 recommendations of the international antiviral society-USA panel. JAMA. 2016;316:191\u2013210. https:\/\/doi.org\/10.1001\/jama.2016.8900.","journal-title":"JAMA"},{"key":"7032_CR6","doi-asserted-by":"publisher","first-page":"388","DOI":"10.5588\/ijtld.20.0956","volume":"25","author":"N Kalema","year":"2021","unstructured":"Kalema N, et al. Gaps in TB preventive therapy for persons initiating antiretroviral therapy in Uganda: an explanatory sequential cascade analysis. Int J Tuberc Lung Dis. 2021;25:388\u201394. https:\/\/doi.org\/10.5588\/ijtld.20.0956.","journal-title":"Int J Tuberc Lung Dis"},{"key":"7032_CR7","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1093\/cid\/cis203","volume":"54","author":"J del Amo","year":"2012","unstructured":"del Amo J, et al. Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries. Clin Infect Dis. 2012;54:1364\u201372. https:\/\/doi.org\/10.1093\/cid\/cis203.","journal-title":"Clin Infect Dis"},{"key":"7032_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25900","volume":"25","author":"G Suwanpimolkul","year":"2022","unstructured":"Suwanpimolkul G, et al. Incidence of active tuberculosis among people living with HIV receiving long-term antiretroviral therapy in high TB\/HIV burden settings in Thailand: implication for tuberculosis preventive therapy. J Int AIDS Soc. 2022;25: e25900. https:\/\/doi.org\/10.1002\/jia2.25900.","journal-title":"J Int AIDS Soc"},{"key":"7032_CR9","first-page":"550","volume":"121","author":"SK Sharma","year":"2005","unstructured":"Sharma SK, Mohan A, Kadhiravan T. HIV-TB co-infection: epidemiology, diagnosis & management. Indian J Med Res. 2005;121:550\u201367.","journal-title":"Indian J Med Res"},{"key":"7032_CR10","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1038\/s41590-019-0447-5","volume":"20","author":"C Gubser","year":"2019","unstructured":"Gubser C, Pitman MC, Lewin SR. CD4(+) T cell signatures in HIV infection. Nat Immunol. 2019;20:948\u201350. https:\/\/doi.org\/10.1038\/s41590-019-0447-5.","journal-title":"Nat Immunol"},{"key":"7032_CR11","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1084\/jem.20070567","volume":"204","author":"A Okoye","year":"2007","unstructured":"Okoye A, et al. Progressive CD4+ central memory T cell decline results in CD4+ effector memory insufficiency and overt disease in chronic SIV infection. J Exp Med. 2007;204:2171\u201385. https:\/\/doi.org\/10.1084\/jem.20070567.","journal-title":"J Exp Med"},{"key":"7032_CR12","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/imr.12066","volume":"254","author":"AA Okoye","year":"2013","unstructured":"Okoye AA, Picker LJ. CD4(+) T-cell depletion in HIV infection: mechanisms of immunological failure. Immunol Rev. 2013;254:54\u201364. https:\/\/doi.org\/10.1111\/imr.12066.","journal-title":"Immunol Rev"},{"key":"7032_CR13","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.trecan.2022.04.004","volume":"8","author":"CC Zebley","year":"2022","unstructured":"Zebley CC, Youngblood B. Mechanisms of T cell exhaustion guiding next-generation immunotherapy. Trends Cancer. 2022;8:726\u201334. https:\/\/doi.org\/10.1016\/j.trecan.2022.04.004.","journal-title":"Trends Cancer"},{"key":"7032_CR14","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1006\/smim.1997.0096","volume":"9","author":"JB Margolick","year":"1997","unstructured":"Margolick JB, Donnenberg AD. T-cell homeostasis in HIV-1 infection. Semin Immunol. 1997;9:381\u20138. https:\/\/doi.org\/10.1006\/smim.1997.0096.","journal-title":"Semin Immunol"},{"key":"7032_CR15","first-page":"172","volume":"5","author":"DC Douek","year":"2003","unstructured":"Douek DC. Disrupting T-cell homeostasis: how HIV-1 infection causes disease. AIDS Rev. 2003;5:172\u20137.","journal-title":"AIDS Rev"},{"key":"7032_CR16","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1097\/qad.0000000000002010","volume":"32","author":"H Roul","year":"2018","unstructured":"Roul H, et al. CD4+ cell count recovery after combined antiretroviral therapy in the modern combined antiretroviral therapy era. AIDS. 2018;32:2605\u201314. https:\/\/doi.org\/10.1097\/qad.0000000000002010.","journal-title":"AIDS"},{"key":"7032_CR17","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1186\/s12879-020-05458-w","volume":"20","author":"V Gopalakrishnan","year":"2020","unstructured":"Gopalakrishnan V, Bose E, Nair U, Cheng Y, Ghebremichael M. Pre-HAART CD4+ T-lymphocytes as biomarkers of post-HAART immune recovery in HIV-infected children with or without TB co-infection. BMC Infect Dis. 2020;20:756. https:\/\/doi.org\/10.1186\/s12879-020-05458-w.","journal-title":"BMC Infect Dis"},{"key":"7032_CR18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12865-019-0311-2","volume":"20","author":"CX Li","year":"2019","unstructured":"Li CX, et al. The predictive role of CD4(+) cell count and CD4\/CD8 ratio in immune reconstitution outcome among HIV\/AIDS patients receiving antiretroviral therapy: an eight-year observation in China. BMC Immunol. 2019;20:31. https:\/\/doi.org\/10.1186\/s12865-019-0311-2.","journal-title":"BMC Immunol"},{"key":"7032_CR19","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1001\/archinte.163.18.2187","volume":"163","author":"GR Kaufmann","year":"2003","unstructured":"Kaufmann GR, et al. CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study. Arch Intern Med. 2003;163:2187\u201395. https:\/\/doi.org\/10.1001\/archinte.163.18.2187.","journal-title":"Arch Intern Med"},{"key":"7032_CR20","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/nm0298-208","volume":"4","author":"NG Pakker","year":"1998","unstructured":"Pakker NG, et al. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation. Nat Med. 1998;4:208\u201314. https:\/\/doi.org\/10.1038\/nm0298-208.","journal-title":"Nat Med"},{"key":"7032_CR21","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/00002030-200202150-00007","volume":"16","author":"GR Kaufmann","year":"2002","unstructured":"Kaufmann GR, et al. The extent of HIV-1-related immunodeficiency and age predict the long-term CD4 T lymphocyte response to potent antiretroviral therapy. AIDS. 2002;16:359\u201367. https:\/\/doi.org\/10.1097\/00002030-200202150-00007.","journal-title":"AIDS"},{"key":"7032_CR22","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1097\/00002030-200005260-00007","volume":"14","author":"GR Kaufmann","year":"2000","unstructured":"Kaufmann GR, Bloch M, Zaunders JJ, Smith D, Cooper DA. Long-term immunological response in HIV-1-infected subjects receiving potent antiretroviral therapy. AIDS. 2000;14:959\u201369. https:\/\/doi.org\/10.1097\/00002030-200005260-00007.","journal-title":"AIDS"},{"key":"7032_CR23","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1097\/00126334-200106010-00012","volume":"27","author":"PM Tarwater","year":"2001","unstructured":"Tarwater PM, et al. Increase and plateau of CD4 T-cell counts in the 3(1\/2) years after initiation of potent antiretroviral therapy. J Acquir Immune Defic Syndr. 2001;27:168\u201375. https:\/\/doi.org\/10.1097\/00126334-200106010-00012.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"7032_CR24","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000027624","volume":"100","author":"GA Manaye","year":"2021","unstructured":"Manaye GA, Abateneh DD, Asmare WN, Abebe M. Factors associated with immunological and virological discordant responses to highly active antiretroviral therapy among adult HIV positive individuals in Ethiopia: a cross-sectional study. Medicine (Baltimore). 2021;100: e27624. https:\/\/doi.org\/10.1097\/md.0000000000027624.","journal-title":"Medicine (Baltimore)"},{"key":"7032_CR25","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1097\/QAD.0b013e328337b957","volume":"24","author":"M Massanella","year":"2010","unstructured":"Massanella M, et al. CD4 T-cell hyperactivation and susceptibility to cell death determine poor CD4 T-cell recovery during suppressive HAART. AIDS. 2010;24:959\u201368. https:\/\/doi.org\/10.1097\/QAD.0b013e328337b957.","journal-title":"AIDS"},{"key":"7032_CR26","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1086\/651689","volume":"50","author":"E Negredo","year":"2010","unstructured":"Negredo E, et al. Nadir CD4 T cell count as predictor and high CD4 T cell intrinsic apoptosis as final mechanism of poor CD4 T cell recovery in virologically suppressed HIV-infected patients: clinical implications. Clin Infect Dis. 2010;50:1300\u20138. https:\/\/doi.org\/10.1086\/651689.","journal-title":"Clin Infect Dis"},{"key":"7032_CR27","doi-asserted-by":"publisher","first-page":"19672","DOI":"10.7448\/ias.17.4.19672","volume":"17","author":"J Saison","year":"2014","unstructured":"Saison J, et al. Relationship between discordant response to HAART, Tregs, immune activation and low-level viraemia. J Int AIDS Soc. 2014;17:19672. https:\/\/doi.org\/10.7448\/ias.17.4.19672.","journal-title":"J Int AIDS Soc"},{"key":"7032_CR28","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.TNMI7-0028-2016","author":"JA Tornheim","year":"2017","unstructured":"Tornheim JA, Dooley KE. Tuberculosis associated with HIV infection. Microbiol Spectr. 2017. https:\/\/doi.org\/10.1128\/microbiolspec.TNMI7-0028-2016.","journal-title":"Microbiol Spectr"},{"key":"7032_CR29","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.TBTB2-0012-2016","author":"E Du Bruyn","year":"2016","unstructured":"Du Bruyn E, Wilkinson RJ. The immune interaction between HIV-1 infection and Mycobacterium tuberculosis. Microbiol Spectr. 2016. https:\/\/doi.org\/10.1128\/microbiolspec.TBTB2-0012-2016.","journal-title":"Microbiol Spectr"},{"key":"7032_CR30","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1080\/02664763.2017.1420758","volume":"45","author":"M Ghebremichael","year":"2018","unstructured":"Ghebremichael M, Habtemicael S. Effect of tuberculosis on immune restoration among HIV-infected patients receiving antiretroviral therapy. J Appl Stat. 2018;45:2357\u201364. https:\/\/doi.org\/10.1080\/02664763.2017.1420758.","journal-title":"J Appl Stat"},{"key":"7032_CR31","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1093\/infdis\/165.2.352","volume":"165","author":"DS Stein","year":"1992","unstructured":"Stein DS, Korvick JA, Vermund SH. CD4+ lymphocyte cell enumeration for prediction of clinical course of human immunodeficiency virus disease: a review. J Infect Dis. 1992;165:352\u201363. https:\/\/doi.org\/10.1093\/infdis\/165.2.352.","journal-title":"J Infect Dis"},{"key":"7032_CR32","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/896040","volume":"2011","author":"L Renner","year":"2011","unstructured":"Renner L, et al. Time to and predictors of CD4+ T-lymphocytes recovery in HIV-infected children initiating highly active antiretroviral therapy in Ghana. AIDS Res Treat. 2011;2011: 896040. https:\/\/doi.org\/10.1155\/2011\/896040.","journal-title":"AIDS Res Treat"},{"key":"7032_CR33","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S2055-6640(20)30510-0","volume":"1","author":"P Palma","year":"2015","unstructured":"Palma P, et al. The EPIICAL project: an emerging global collaboration to investigate immunotherapeutic strategies in HIV-infected children. J Virus Erad. 2015;1:134\u20139.","journal-title":"J Virus Erad"},{"key":"7032_CR34","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1093\/infdis\/jir787","volume":"205","author":"J Lewis","year":"2012","unstructured":"Lewis J, et al. Age and CD4 count at initiation of antiretroviral therapy in HIV-infected children: effects on long-term T-cell reconstitution. J Infect Dis. 2012;205:548\u201356. https:\/\/doi.org\/10.1093\/infdis\/jir787.","journal-title":"J Infect Dis"},{"key":"7032_CR35","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1016\/s0140-6736(13)61409-9","volume":"382","author":"MF Cotton","year":"2013","unstructured":"Cotton MF, et al. Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial. Lancet. 2013;382:1555\u201363. https:\/\/doi.org\/10.1016\/s0140-6736(13)61409-9.","journal-title":"Lancet"},{"key":"7032_CR36","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1097\/01.qai.0000152400.36723.85","volume":"39","author":"MS Dworkin","year":"2005","unstructured":"Dworkin MS, et al. Factors that complicate the treatment of tuberculosis in HIV-infected patients. J Acquir Immune Defic Syndr. 2005;39:464\u201370. https:\/\/doi.org\/10.1097\/01.qai.0000152400.36723.85.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"7032_CR37","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1186\/s12879-016-1916-1","volume":"16","author":"S Mutembo","year":"2016","unstructured":"Mutembo S, Mutanga JN, Musokotwane K, Alisheke L, Whalen CC. Antiretroviral therapy improves survival among TB-HIV co-infected patients who have CD4+ T-cell count above 350cells\/mm(3). BMC Infect Dis. 2016;16:572. https:\/\/doi.org\/10.1186\/s12879-016-1916-1.","journal-title":"BMC Infect Dis"},{"key":"7032_CR38","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1097\/QAI.0b013e318288b39d","volume":"63","author":"M Schomaker","year":"2013","unstructured":"Schomaker M, et al. Immune recovery after starting ART in HIV-infected patients presenting and not presenting with tuberculosis in South Africa. J Acquir Immune Defic Syndr. 2013;63:142\u20135. https:\/\/doi.org\/10.1097\/QAI.0b013e318288b39d.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"7032_CR39","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1093\/cid\/cir900","volume":"54","author":"A Cingolani","year":"2012","unstructured":"Cingolani A, et al. Impaired CD4 T-cell count response to combined antiretroviral therapy in antiretroviral-naive HIV-infected patients presenting with tuberculosis as AIDS-defining condition. Clin Infect Dis. 2012;54:853\u201361. https:\/\/doi.org\/10.1093\/cid\/cir900.","journal-title":"Clin Infect Dis"},{"key":"7032_CR40","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1089\/aid.2012.0192","volume":"29","author":"NS Ku","year":"2013","unstructured":"Ku NS, et al. Effects of tuberculosis on the kinetics of CD4(+) T cell count among HIV-infected patients who initiated antiretroviral therapy early after tuberculosis treatment. AIDS Res Hum Retroviruses. 2013;29:226\u201330. https:\/\/doi.org\/10.1089\/aid.2012.0192.","journal-title":"AIDS Res Hum Retroviruses"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-024-07032-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13104-024-07032-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-024-07032-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T21:05:48Z","timestamp":1736283948000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-024-07032-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,7]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7032"],"URL":"https:\/\/doi.org\/10.1186\/s13104-024-07032-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4243586\/v1","asserted-by":"object"}]},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,7]]},"assertion":[{"value":"9 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the ethical standards of the institutional and\/or national research committee and the Declaration of Helsinki. Informed consent to participate was obtained from the participants and the study protocol received approval from the Yale University Human Investigation Committee and the University of Ghana Medical School.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6"}}